Roche has announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. This test is designed to aid physicians in the diagnosis of throat cancer, bowel cancer, and breast cancer in patients, in conjunction with ot...
|